Does an AI-filled future seem like promise or peril to today's teens and tweens? We went right to the source. When we set out to talk to kids about artificial intelligence, we thought we knew what we'd hear. We expected some to tell us they were using it to cheat a little, the way Millennials and Gen Xers opened up CliffsNotes or programmed formulas into their TI-82s, and others to share inspiring ways they were using it. We were also listening for concerns that were less kid-specific, like deepfakes or job destruction. But what we actually heard when we asked kids aged 10 to 18 about AI had tons of nuance. Many of the same kids who can go on and on about music, rock climbing, or soccer met our questions with words like "bruh" and "meh"--or were so deeply against AI or uninterested in making it part of their lives that they didn't want to talk about it at all. One teen said his peers use it for things they know they shouldn't, like writing papers. One told us she won't touch AI because of the environmental impact. A few said they find the whole field disheartening: "AI isn't the solution to our problems," said Winter, a 17-year-old.

Image caption, More than 2,000 images were taken of Ruth's skin I don't mind having my photo taken - triple checked and filtered for Instagram - but 70 cameras pointing at me while I'm down to my knickers is a bit daunting. A robotic voice tells me to stay still and close my eyes as I stand in a huge curved scanner while classical music plays in the background. With a flash of light, 2,000 photographs are taken of my body, in the hope of capturing every mark, freckle and mole to analyse for different skin cancers. This full-body scan is happening at a sci-fi-style clinic in Manchester city centre, with me wearing a dressing gown and hexagon-shaped rubber slippers. The millions of data points collected will create a 3D avatar of my body using AI.

There is growing interest in using machine learning (ML) to support clinical diagnosis, but most approaches rely on static, fully observed datasets and fail to reflect the sequential, resource-aware reasoning clinicians use in practice. Diagnosis remains complex and error prone, especially in high-pressure or resource-limited settings, underscoring the need for frameworks that help clinicians make timely and cost-effective decisions. We propose ACTMED(Adaptive Clinical Test selection via Model-based Experimental Design), a diagnostic framework that integrates Bayesian Experimental Design (BED) with large language models (LLMs) to better emulate real-world diagnostic reasoning. At each step, ACTMED selects the test expected to yield the greatest reduction in diagnostic uncertainty for a given patient. LLMs act as flexible simulators, generating plausible patient state distributions and supporting belief updates without requiring structured, task-specific training data. Clinicians can remain in the loop; reviewing test suggestions, interpreting intermediate outputs, and applying clinical judgment throughout. We evaluate ACTMEDon real-world datasets and show it can optimize test selection to improve diagnostic accuracy, interpretability, and resource use. This represents a step toward transparent, adaptive, and clinician-aligned diagnostic systems that generalize across settings with reduced reliance on domain-specific data.

This paper proposes a deep reinforcement learning (DRL)-based event-triggered controller design for networked artificial pancreas (AP) systems. Although existing DRL-based AP controllers typically assume periodic control updates, networked control systems (NCSs) require a reduction in communication frequency to achieve energy-efficient operation, which is directly tied to control updates. However, jointly learning both insulin dosing and update timing significantly increases the complexity of the learning problem. To alleviate this complexity, we develop a practical DRL-based controller design that avoids explicitly learning update timing by introducing a rule-based criterion defined by changes in blood glucose. As a result, decision-making occurs at irregular intervals, and the problem is naturally formulated as a semi-Markov decision process (SMDP), for which we extend a standard DRL algorithm. Numerical experiments demonstrate that the proposed method improves communication efficiency while maintaining control performance.

Bayesian predictive intervals are conditioned on the specific observed sequenceZ1:n and make statements on the next value[Yn+1 | Xn+1]. Subjective Bayesian statements on predictions are non-refutable, and are in this sense unscientific, but are optimal according to decision theoretic foundations. However,tomakesuch strong statements, the Bayesian must usually make the strict assumption of the model being well-specified. Asmentionedearlier,computingtheAOI interval is an efficient matrix-vector multiplication, whereas the LOO interval requires expensive broadcastingtoconstructthe ngrid T nISweightarray. We use the same Bayesian model as in (10), again consideringc=1,0.02.

We use 9 datasets and pre-trained models provided in Chen et al. (2019b), which can be downloaded Methods on the bottom-left corner are better. For completeness we include verification results (Chen et al., 2019b; Wang et al., 2020) in

We have 2 large datasets, HIGGS and Bosch (see reply to[R3]-1)). Table B highlights our differences.3) Motivation: We provide a strong attack as a tool for evaluating the9 robustnessoftreebasedmodels. MILP uses a thin wrapper around the Gurobi Solver.

All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. Currently, many young people go undiagnosed and risk developing a life-threatening complication called diabetic ketoacidosis that needs urgent hospital treatment. Identifying diabetes earlier could help avoid this and mean treatments to control problematic blood sugar levels can be given sooner. Some 17,000 children aged three to 13 have already been checked as part of the ELSA (Early Surveillance for Autoimmune diabetes) study, funded by diabetes charities. Imogen, who is 12 and from the West Midlands, is one of those found to have diabetes thanks to the screening.

PreEvnt isaac aims to reduce finger pricks for diabetics by analyzing breath compounds to detect glucose changes, offering smartphone alerts and emergency contact notifications.